Funding Received
$62.5 Million in 1 Round from 4 Investors
Most Recent Funding
$62.5 Million Series C on December 21, 2007
Founded:
2006
Headquarters:
Menlo Park, CA
Description:
Cogentus Pharmaceuticals is a company focused on developing prescription pharmaceutical products in North America and Europe.
Categories:
Biotechnology
Website:
http://www.cogentus.net

Detailed Description

Update

Cogentus Pharmaceuticals, Inc., a pharmaceutical company, develops prescription pharmaceutical products in North America and Europe. It develops CGT-2168, an oral formulation that combines clopidogrel with a gastroprotectant, which reduces the gastrointestinal side effects associated with dual antiplatelet therapy. The company was founded in 2006 and is based in Menlo Park, California. On January 16, 2009, Cogentus Pharmaceuticals, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California.

Past Team (3)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • HQ

    301 Ravenswood Avenue

    Suite 100

    Menlo Park, CA 94025

    USA